Accepted for Publication: March 12, 2019.
Corresponding Author: Pooja Lagisetty, MD, MSc, NCRC B16-Floor 2, 2800 Plymouth Rd, Ann Arbor, MI 48109 (lagiset@med.umich.edu).
Published Online: May 8, 2019. doi:10.1001/jamapsychiatry.2019.0876
Author Contributions: Dr Lagisetty and Mr Ross had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Lagisetty.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Lagisetty, Ross, Maust.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Ross.
Administrative, technical, or material support: Lagisetty, Clay.
Supervision: Lagisetty, Maust.
Other - mentoring: Bohnert.
Conflict of Interest Disclosures: None reported.
6.Parran
TV, Muller
JZ, Chernyak
E,
et al. Access to and payment for office-based buprenorphine treatment in Ohio.
Subst Abuse. 2017;11:1178221817699247.
PubMedGoogle Scholar